Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease

Canadian Journal of Gastroenterology and Hepatology

Volumn 28, Issue 7, 2014, Pages 361-370

  Iacucci, M ^a   Uraoka, T ^b   Fort Gasia, M ^a   Yahagi, N ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Chromoendoscopy; Confocal laser endomicroscopy; Endoscopic submucosal dissection; High definition endoscopic technique iScan; Inflammatory bowel disease; Narrow band imaging

Indexed keywords

DYE; INDIGO CARMINE; METHYLENE BLUE;

AUTOFLUORESCENCE IMAGING; CANCER INCIDENCE; CHROMOENDOSCOPY; CHRONIC INFLAMMATION; COLON ADENOMA; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; CONFOCAL LASER MICROSCOPY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DYSPLASIA; ENDOCYTOSCOPY; ENDOSCOPE; ENDOSCOPIC SUBMUCOSAL DISSECTION; FILTER; HISTOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; MEDICAL TECHNOLOGY; META ANALYSIS (TOPIC); NARROW BAND IMAGING; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PROCTOCOLECTOMY; REVIEW; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; COLORECTAL NEOPLASMS; COMPLICATION; DECISION SUPPORT SYSTEM; DEVICES; PROCEDURES;

COLONOSCOPY; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC IMAGING; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84905855410     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2014/825947     Document Type: Review

References (79)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35. (Pubitemid 32234798)
2. Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013;145:166-75.
3. Loftus EV Jr. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006;35:517-31.
4. Jess T, Simonsen J, Jørgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012;143:375-81.
5. Stolfi C, Pellegrini R, Franze E, et al. Molecular basis of the potential of mesalazine to prevent colorectal cancer. World J Gastroenterol 2008;14:4434-9.
6. Andersen NN, Jess T. Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol 2013;43:7561-8.
7. Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: A case-control study. Clin Gastroenterol Hepatol 2013;11:1601-8.
8. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis. Gastrointest Endosc 2002;56:48-54. (Pubitemid 41115048)
9. Kaplan GG, Heitman SJ, Hilsden RJ, et al. Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis. Inflamm Bowel Dis 2007;13:1401-7. (Pubitemid 350206853)
10. Jess T, Gamborg M, Matzen P. Increased risk of intestinal cancer in Crohn's disease: A meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724-9.
11. Canavan C, Abrams KR, Mayberry J, et al. Meta-analysis: Colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006;23:1097-104. (Pubitemid 43779348)
12. Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: An updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013;19:789-99.
13. Farraye FA, RD, Odze RD, Eaden J, et al. AGA Medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:738-45.
14. Ullman T, Croog V, Harpaz N, et al. Virtually all CRC develop from dysplastic precursor lesions. Gastroenterology 2003;25:1311-9.
15. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-48. (Pubitemid 38649879)
16. Rutter M, Bernstein C, Matsumoto T, et al. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004;36:1109-14. (Pubitemid 39642475)
17. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999;117:1295-300.
18. Schneider A, Stolte M. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol 1993;31:653-6. (Pubitemid 23350746)
19. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
20. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5. (Pubitemid 30489769)
21. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.
22. Efthymiou M, Taylor AC, Kamm MA. Cancer surveillance strategies in ulcerative colitis: The need for modernization. Inflamm Bowel Dis 2011;17:1800-13.
23. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: A population-based study from Olmsted County, Minnesota. Gastroenterology 2006;130:1039-46.
24. Collins PD Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006;CD000279.
25. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: A case-control study. Aliment Pharmacol Ther 2000;14:145-53. (Pubitemid 30088290)
26. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance. Gastrointest Endosc 2000;51:123-8. (Pubitemid 30094501)
27. Obrador A, Ginard D, Barranco L. Review article: Colorectal cancer surveillance in ulcerative colitis - what should we be doing? Aliment Pharmacol Ther 2006;24:56-63. (Pubitemid 44326422)
28. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60. (Pubitemid 38125515)
29. Baars JE, Vogelaar L, Wolfhagen FH, et al. A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: Results from a randomized controlled trial. J Crohns Colitis 2010;4:661-8.
30. Corte C, Dahlenburg L, Selby W, et al. Hyoscine butylbromide administered at the cecum increases polyp detection: A randomized double-blind placebo-controlled trial. Endoscopy 2012;44:917-22.
31. East JE, Stavrindis M, Thomas-Gibson S, et al. A comparative study of standard vs. high definition colonoscopy for adenoma and hyperplastic polyp detection with optimized withdrawal technique. Aliment Pharmacol Ther 2008;28:768-76.
32. Kiesslich R, MF Neurath. Chromoendoscopy and other novel imaging techniques. Gastroenterol Clin North Am 2006;35:605-19. (Pubitemid 44307576)
33. Kiesslich R, Neurath MF. Chromoendoscopy in inflammatory bowel disease. Gastroenterol Clin North Am 2012;41:291-302.
34. Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14. (Pubitemid 26268652)
35. Subramanian V, Mannath J, Ragunath K, et al. Meta-analysis: The diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:304-12.
36. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8. (Pubitemid 36389789)
37. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: A prospective endoscopic trial. Am J Gastroenterol 2008;103:2342-9.
38. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: A prospective evaluation. Endoscopy 2005;37:1186-92. (Pubitemid 41763534)
39. Bessissow T, Bisschops R. Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis. Expert Rev Gastroenterol Hepatol 2013;7:57-67.
40. Konijeti GG, Shrime MG, Ananthakrishnan AN, et al. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc 2013;S0016-5107.
41. SubramanianV, Ramappa V, Telakis E, et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013;19:350-5.
42. Dekker E, van den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007;39:216-21. (Pubitemid 46510792)
43. van den Broek FJ, Fockens P, van Eeden S, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011;43:108-15.
44. Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: A randomized controlled trial. Am J Gastroenterol 2012;10:885-90.
45. Efthymiou M, Allen PB, Taylor AC, et al. Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease.Inflamm Bowel Dis 2013;19:2132-8.
46. Pellisé M, López-Cerón M, Rodríguez de Miguel C, et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: A prospective, randomized, crossover study. Gastrointest Endosc 2011;74:840-8.
47. van den Broek FJ, Fockens P, Van Eeden SE, et al. Clinical evaluation of endoscopic trimodal imaging for the detection and differentiation of colonic polyps. Clin Gastroenterol Hepatol 2009;7:288-95.
48. van den Broek FJ, Fockens P, van Eeden S, et al. Endoscopic trimodal imaging for surveillance in ulcerative colitis: Randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008;57:1083-9.
49. Kodashima S, Fujishiro M. Novel image-enhanced endoscopy with i-SCAN technology. World J Gastroenterol 2010;16:1043-9.
50. Hoffman A, Kagel C, Goetz M, et al. Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-SCAN is as precise as chromoendoscopy. Dig Liver Dis 2010;42:45-50.
51. Hong SN, Choe WH, Lee JH, et al. Prospective, randomized, back-to-back trial evaluating the usefulness of i-SCAN in screening colonoscopy. Gastrointest Endosc 2012;75:1011-21.
52. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007;132:874-82. (Pubitemid 46440874)
53. Kiesslich R, Burg J, Vieth M, et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004;127:706-13. (Pubitemid 39208403)
54. Wallace MB, Fockens P. Probe-based confocal laser endomicroscopy. Gastroenterology 2009;36:1509-13.
55. Wallace M.B, Meining A, Canto MI, et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther 2010;31:548-52.
56. Neumann H, Vieth M, Neurath MF. Image of the month. Endocytoscopy-based detection of focal high-grade intraepithelial neoplasia in colonic polyps. Clin Gastroenterol Hepatol 2011;9:13.
57. Kudo SE, Wakamura K, Ikehara N, et al. Diagnosis of colorectal lesions with a novel endocytoscopic classification - a pilot study. Endoscopy 2011;43:869-75.
58. Pekow JR. Hetzel JT, Rothe JA, et al. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis 2010;16:1352-6.
59. Hurlstone DP, Sanders DS, Atkinson R, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: Can we change the endoscopic management paradigm? Gut 2007;56:838-46. (Pubitemid 46854201)
60. Kisiel JB, Loftus EV Jr, Harmsen WS, et al. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy. Inflamm Bowel Dis 2012;18:226-35.
61. Rubio CA, Befrits R, Jaramillo E, et al. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res 2000; 20:4761-4. (Pubitemid 32127724)
62. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end-points. Am J Surg Pathol 2006;30:1491-501. (Pubitemid 44808785)
63. Chaubert P, Benhattar J, Saraga E, et al. K-ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994;144:767-75. (Pubitemid 24172065)
64. Bossard C, Denis MG, Bezieau S, et al. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 2007;18:1093-7.
65. Soetikno RM, Gotoda T, Nakanishi Y, et al. Endoscopic mucosal resection. Gastrointest Endosc 2003;57:567-79. (Pubitemid 36406373)
66. Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc 2010;72:1217-25.
67. Uraoka T, Parra-Blanco A, Yahagi N. Colorectal endoscopic submucosal dissection in Japan and Western countries. Dig Endosc 2012;24:80-3.
68. Uraoka T, Parra-Blanco A, Yahagi N. Colorectal endoscopic submucosal dissection: Is it suitable in western countries? J Gastroenterol Hepatol 2013;28:406-14.
69. Draganov PV, Gotoda T, Chavalitdhamrong D, et al. Techniques of endoscopic submucosal dissection: Application for the Western endoscopist? Gastrointest Endosc 2013;78:677-88.
70. Repici A, Hassan C, De Paula Pessoa D, et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: A systematic review. Endoscopy 2012;44:137-50.
71. Iacucci M, Eustace G, Uraoka T, et al. Endoscopic submucosal dissection in the colorectum: Feasibility in the Canadian setting. Can J Gastroenterol 2013;27:689-93.
72. Kuroki Y, Hoteya S, Mitani T, et al. Endoscopic submucosal dissection for residual/locally recurrent lesions after endoscopic therapy for colorectal tumors. J Gastroenterol Hepatol 2010;25:1747-53.
73. Wanders LK, Dekker E, Pullens B, et al. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: A meta-analysis. Clin Gastroenterol Hepatol 2013: S1542-3565.
74. Jonathan A, Leighton BS, Baron TH, et al. ASGE guideline: Endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006;63:558-65.
75. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35. (Pubitemid 32234798)
76. Wong NA, Mayer NJ, MacKell S, et al. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia. Histopathology 2000;37:108-14. (Pubitemid 30608507)
77. Sato A, MacHinami R. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma. Pathol Int 1999;49:858-68.
78. Smith LA, Baraza W, Tiffin N, et al. Endoscopic resection of adenoma-like mass in chronic ulcerative colitis using a combined endoscopic mucosal resection and cap assisted submucosal dissection technique. Inflamm Bowel Dis 2008;14:1380-6.
79. Velayos FS, Loftus EV, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006;130:1941-9. (Pubitemid 43816957)